NCRP Report Available: Report No. 168 - Radiation Dose Management for Fluoroscopically-Guided Interventional Medical Procedures

This Report is focused on the use of fluoroscopic systems as a tool for guiding diagnostic and therapeutic procedures because higher radiation doses (compared to conventional radiography and fluoroscopy) are received regularly from some types of FGI procedures and occasionally from many other types of FGI procedures. Other medical applications of fluoroscopy (e.g., examination of the gastrointestinal system, guiding open surgical procedures) are outside the scope of this Report. Computed-tomography-guided interventional (CTGI) procedures are not discussed in detail due to continuing changes in the technology driven by the evolution of multi-slice computed tomography (CT) detectors. However, the principles presented in this Report are generally applicable to these domains. Most of the recommendations contained in this Report should be applied in all settings where fluoroscopic guidance is used.

report available form: NCRP Publications

Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System

New system integrates market-leading Renegade HI-FLO Microcatheter with high-torque Fathom-16 Steerable Guidewire for peripheral embolization procedures

NATICK, Mass., Jan. 31, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved its Renegade® HI-FLO™ Fathom® Pre-Loaded System for selective access and delivery of diagnostic, embolic and therapeutic materials into the peripheral vasculature. The system will primarily be used by interventional radiologists for minimally invasive procedures to treat uterine fibroids and liver cancer. The Company said it plans to launch the product immediately in the United States.

The Renegade HI-FLO Fathom Pre-Loaded System combines the turn-for-turn torque response, flexibility and high visibility of the Fathom-16 Steerable Guidewire with the clinically proven performance of the Renegade HI-FLO Microcatheter, pre-loaded in a single convenient platform. The system will be available in eight configurations to suit a broad range of peripheral embolization procedures.

"The excellent deliverability, torque transmission and flow capacity of the Renegade HI-FLO Fathom Pre-Loaded System provides physicians with the performance they need to efficiently access tortuous vessels across many types of interventional oncology procedures," said Jeff Geschwind, M.D., Professor of Radiology, Surgery and Oncology, and Director of Vascular and Interventional Radiology at the Johns Hopkins University School of Medicine.

source: PR Newswire